Patent: 7,553,836
✉ Email this page to a colleague
Summary for Patent: 7,553,836
| Title: | Melanin concentrating hormone receptor-1 antagonists |
| Abstract: | The present application provides compounds, including all stereoisomers, solvates, prodrugs and pharmaceutically acceptable forms thereof according to Formula I ##STR00001## wherein R.sup.1a, R.sup.1b, R.sup.1c, Q, A, R.sup.3, W, D and R.sup.2 are defined herein. Additionally, the present application provides pharmaceutical compositions containing at least one compound according to Formula I and optionally at least one additional therapeutic agent. Finally, the present application provides methods for treating a patient suffering from an MCHR-1 modulated disease or disorder such as, for example, obesity, diabetes, depression or anxiety by administration of a therapeutically effective dose of a compound according to Formula I. |
| Inventor(s): | Zhao; Guohua (Princeton, NJ) |
| Assignee: | Bristol-Myers Squibb Company (Princeton, NJ) |
| Application Number: | 11/671,150 |
| Patent Claims: | see list of patent claims |
Details for Patent 7,553,836
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Jubilant Hollisterstier Llc | N/A | positive skin test control-histamine | Injection | 103891 | 03/13/1924 | ⤷ Try a Trial | 2026-02-06 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
